Rockwell Medical (RMTI) Total Debt Growth (1y) (2014 - 2026)
Rockwell Medical (RMTI) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -13.33% |
| 10 | Rockwell Medical | 26.80 Mn | 2.91 Mn | 2.90 Mn | -18.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.93% |
| Dec 31, 2025 | -9.38% |
| Sep 30, 2025 | -1.13% |
| Jun 30, 2025 | 3.27% |
| Mar 31, 2025 | 2.14% |
| Dec 31, 2024 | 0.46% |
| Sep 30, 2024 | 82.76% |
| Jun 30, 2024 | 101.25% |
| Mar 31, 2024 | 243.82% |
| Dec 31, 2023 | 405.76% |
| Sep 30, 2023 | -58.62% |
| Jun 30, 2023 | -65.40% |
| Mar 31, 2023 | -82.99% |
| Dec 31, 2022 | -89.62% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -26.65% |
| Mar 31, 2022 | -13.21% |
| Dec 31, 2021 | -2.43% |
| Sep 30, 2021 | -32.88% |
| Jun 30, 2021 | 0.86% |